Diagnosis

Vitiligo

An autoimmune disease characterized by destruction of melanocytes that is characterized by hypopigmentation.

Etiology

Cause [mh9][ub2]

Pathophysiology [ub2]

  1. Melanocytes are selectively destroyed --> absence of melanocytes --> depigmentation

  2. Theories of melanocyte destruction: cytotoxic mechanisms, intrinsic melanocyte defects, neural mechanisms, and oxidant-antioxidant mechanisms

  3. Associated with thyroid abnormalities

  4. Clinical presentation:

    • Trichrome

    • Marginal inflammatory

    • Quadrichrome

    • Koebner phenomenon

    • Localization:

      • Hands

      • Forearms

      • Feet

      • Face: periocular or perioral distribution

  5. Classification:

    • Generalized

    • Segmental

    • Localized

Complications [mh9]

Epidemiology

Incidence per 100.000 [ovs][ydy][mh9]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Koebner phenomenon, Leukotrichia

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Distribution
AsymmetricGeneralizedLocalizedMultipleSingleSymmetric
Lesion type
HypopigmentationMacule
Lesion configuration
Koebner phenomenon
Color
BlueBrownWhite
Associated symptom
Itch

Approach

Treatment

  1. Spontaneous repigmentation may occur but is uncommon [mh9]

  2. Topical: corticosteroids, calcineurin inhibitors, and vitamin D analogs [ub2]

  3. Phototherapy: UV-B 2-3/week induces repigmentation in early disease

  4. Laser therapy: Excimer Laser to treat limited, stable patches of vitiligo

  5. Systemic: if resistant disease, tacrolimus and systemic corticosteroids

  6. Surgical repigmentation: if segmental/localized disease [ub2]

    • Non cultured epidermal suspensions

    • Thin dermo-epidermal grafts

    • Suction epidermal grafts

    • Punch grafting

    • Cultured epidermis with melanocytes

Differential diagnoses

Adrenal insufficiency, Alezzandrini Syndrome, Cutaneous T-cell lymphoma, Drug eruptions, Eczema, Idiopathic guttate hypomelanosis, Leishmaniasis, Leporsy, Leprosy, Leukoderma, Lichen sclerosus, Lichen striatus, Malignant melanoma, Mycosis fungoides, Nevus, Nevus anemicus, Onchocerciasis, Piebaldism, Pityriasis alba, Pityriasis versicolor, Psoriasis, Systemic lupus erythematosus, Systemic sclerosis, Treponematosis, Tuberous sclerosis, Vogt-Koyanagi-Harada syndrome, Waardenburg syndrome


References

[1] Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011 Sep;65(3):473-491.

[2] Ahmed jan N, Masood S. Vitiligo. Updated 2023 Aug 7: https://www.ncbi.nlm.nih.gov/books/NBK559149/

[3] Mastacouris N, Strunk A, Garg A. Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US. JAMA Dermatol. 2023 Sep 1;159(9):986-990.

[4] Rueda PA, Orozco S, Castro JR, Londoño AM, Vásquez EM, Arango A, et al. Epidemiology of vitiligo: incidence and prevalence by gender and age in Colombian population. Biomédica. 2025;45 (4).

[5] http://emedicine.medscape.com/article/1068962; [Medscape]

Scroll to top